LTRN Q2 2020 Earnings — Lantern Pharma Inc. Revenue & Financial Results | Market Cap Arena

LTRNLantern Pharma Inc.

$30M

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$833,422

Net Income

-$833,422

EPS (Diluted)

$-0.14

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$490,870

Free Cash Flow

-$498,690

Stock-Based Comp.

$105,363

Balance Sheet

Total Assets

$26M

Total Liabilities

$2M

Stockholders' Equity

$23M

Cash & Equivalents

$24M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$833,422	-$629,393	-32.4%
Net Income	-$833,422	-$629,393	-32.4%